AD pathology is cardinally marked by the accumulation of Aβ (Amyloid-β, a proteolytic product from APP processing), which in turn fuels the formation of amyloid plaques and neurogenic fibril tangles of tau protein (NFTs) [84,85,86]. This evidence concerns the gene APP and Alzheimer disease.